Latest

Latest Pfizer News | Page 2

  • Latest Pfizer news stories and updates. What is happening today? All recent Pfizer news and developments. Live coverage and timeline of Pfizer. All you need to know about Pfizer.
Karin Holmsten awarded newly established scholarship from the Swedish Society for Urological Oncology
Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
Elimination of trachoma as a public health problem in India
Is it COVID-19? Flu? At-home rapid tests could help you and your doctor decide on a treatment plan
One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics
WHO validates the elimination of trachoma as a public health problem in Pakistan
Your gas stove might be making your asthma worse. Here’s what you can do about it
New initiative boosts Aboriginal and Torres Strait Islander pharmacy leadership
COVID-19, flu and RSV shots − an epidemiologist explains why all three matter this fall
‘We think the life sciences sector should be central to our national growth’
Pfizer upgrades Melbourne plant making it one of the most advanced facilities in Australia
Sarcopenic obesity can rob people of their strength – but even brief bursts of exercise help a lot
Pfizer upgrades its plant in Melbourne to become one of the most advanced pharmaceutical production facilities in Australia
No increased risk of birth defects after COVID-19 infection or vaccination in the first trimester
Using MRNA Technology To Prevent Cancer And Treat Disease
Lupus is more common and severe in Aboriginal and Torres Strait Islander peoples. Learning why is crucial
Little Trust In Dr. ChatGPT
Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes
Study Backs RSV Vaccine Safety During Pregnancy
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health
Masks work, our comprehensive review has found
Caroline Ran Receives Research Grant in Migraine Studies
Too many Australians aren’t getting a flu vaccine. Why, and what can we do about it?
New sickle cell disease drug approved for use in England – here’s how voxelotor works
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
We looked at genetic clues to depression in more than 14,000 people. What we found may surprise you
Migraine sufferers in England may soon be able to access preventative drug – here’s how atogepant works
Three quarters of Australians at higher risk of serious illness from COVID-19 do not have a COVID plan with their GP
Constitutional complaint brought against Federal Court Judge for concealing pharma connections
Cell & Gene Catalyst submits feedback on HTA consultation
Study Shows How Oestrogen Protects Against Fatty Liver
New Monitoring Tool Is Making Vaccine Rollouts Safer
Jane Morgan and Brian Leedman Appointed to the Board of Directors of BlinkLab – Early and Accurate Detection of Autism using an…
An RSV vaccine has been approved for people over 60. But what about young children?
Space travel taxes astronauts’ brains. But microbes on the menu could help in unexpected ways
Discovery of drug candidate to potentially tackle ER-positive breast cancer
One-third of Australians do not believe COVID-safe measures are important ahead of the holiday season
New COVID vaccine in pharmacies from today
XELJANZ® (tofacitinib citrate) PBS-listed for patients aged 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA)
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Australia’s Cell and Gene Catalyst calls for Expressions of Interest
Could antivirals reduce your risk of long COVID? Where the research is up to on prevention and treatment
New Covid vaccines available to target current variants
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
Medical manufacturing boost to create local jobs
Director appointed to Australia’s Cell and Gene Catalyst
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer
TGA Product Information safety updates 13 September

© 2026 - The National Tribune Australia